Price Alert

Collegium Pharmaceutical ... (COLL)

NASDAQ: COLL · Real-Time Price · USD

37.68

0.52 (1.40%)

At close: Aug 15, 2025, 1:22 PM

Collegium Pharmaceutical Statistics

Share Statistics

Collegium Pharmaceutical has 32.14M shares outstanding. The number of shares has increased by -0.22% in one year.

Shares Outstanding	32.14M
Shares Change (YoY)	-0.22%
Shares Change (QoQ)	2.09%
Owned by Institutions (%)	99.99%
Shares Floating	30.18M
Failed to Deliver (FTD) Shares	43
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 4.21M, so 13.09% of the outstanding shares have been sold short.

Short Interest	4.21M
Short % of Shares Out	13.09%
Short % of Float	15.63%
Short Ratio (days to cover)	14.22

Valuation Ratios

The PE ratio is 13.36 and the forward PE ratio is 5.15. Collegium Pharmaceutical's PEG ratio is 0.4.

PE Ratio	13.36
Forward PE	5.15
PS Ratio	1.46
Forward PS	1.5
PB Ratio	4.04
P/FCF Ratio	4.55
PEG Ratio	0.4

Financial Ratio History

Enterprise Valuation

Collegium Pharmaceutical has an Enterprise Value (EV) of 1.71B.

EV / Sales	2.71
EV / EBITDA	5.01
EV / EBIT	8.36
EV / FCF	8.43

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 3.75.

Current Ratio	0.95
Quick Ratio	0.88
Debt / Equity	3.75
Debt / EBITDA	2.51
Debt / FCF	4.23
Interest Coverage	2.3

Financial Efficiency

Return on Equity is 30.23% and Return on Invested Capital is 9.77%.

Return on Equity	30.23%
Return on Assets	4.16%
Return on Invested Capital	9.77%
Revenue Per Employee	$1.77M
Profits Per Employee	$193.81K
Employee Count	357
Asset Turnover	0.38
Inventory Turnover	7.15

Taxes

Income Tax	29.38M
Effective Tax Rate	29.8%

Stock Price Statistics

The stock price has increased by 1.49% in the last 52 weeks. The beta is 0.68, so Collegium Pharmaceutical's price volatility has been higher than the market average.

Beta	0.68
52-Week Price Change	1.49%
50-Day Moving Average	30.73
200-Day Moving Average	30.3
Relative Strength Index (RSI)	67.1
Average Volume (20 Days)	307,988

Income Statement

In the last 12 months, Collegium Pharmaceutical had revenue of 631.45M and earned 69.19M in profits. Earnings per share was 2.14.

Revenue	631.45M
Gross Profit	377.34M
Operating Income	169.9M
Net Income	69.19M
EBITDA	341.7M
EBIT	172.54M
Earnings Per Share (EPS)	2.14

Full Income Statement

Balance Sheet

The company has 70.56M in cash and 859.3M in debt, giving a net cash position of -788.73M.

Cash & Cash Equivalents	70.56M
Total Debt	859.3M
Net Cash	-788.73M
Retained Earnings	-164M
Total Assets	1.63B
Working Capital	40.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 204.98M and capital expenditures -1.65M, giving a free cash flow of 203.33M.

Operating Cash Flow	204.98M
Capital Expenditures	-1.65M
Free Cash Flow	203.33M
FCF Per Share	6.3

Full Cash Flow Statement

Margins

Gross margin is 59.76%, with operating and profit margins of 26.91% and 10.96%.

Gross Margin	59.76%
Operating Margin	26.91%
Pretax Margin	15.61%
Profit Margin	10.96%
EBITDA Margin	54.11%
EBIT Margin	26.91%
FCF Margin	32.2%

Dividends & Yields

COLL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	7.48%
FCF Yield	21.99%

Dividend Details

Analyst Forecast

The average price target for COLL is $44, which is 21.7% higher than the current price. The consensus rating is "Buy".

Price Target	$44
Price Target Difference	21.7%
Analyst Consensus	Buy
Analyst Count	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$47.87
Lynch Upside	32.42%
Graham Number	18.49
Graham Upside	-48.85%

Scores

Altman Z-Score	1.04
Piotroski F-Score	5